ABCLCIK 1703057

AbCellera Biologics Inc.

EDGAR filings

Customers

None disclosed

Suppliers

1 disclosed

Latest period

Dec 31, 2025

10-K filed 2026-03-10

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Suppliers 1

Companies that disclose ABCL as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from ABCL	Period	Trend	Status	Source
PRLD Prelude Therapeutics Inc	Named	—	FY 2025-12-31	—	Active	10-K 2026-03-10
The Company assessed the Amended Agreement signed in accordance with ASC 606, Revenue from Contracts with Customer, and concluded that AbCellera is a customer in the context of the Amended Agreement. 10-K filed 2026-03-10 Period FY 2025-01-01 to 2025-12-31Accession 0001193125-26-099428

Unnamed major customers

Disclosed without names in the fiscal year ending 2024-12-31. Identities are not inferred.

Customer One47%
Customer Two22%

Alerts are coming

Get an email when ABCL's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.